NewCardio(OTC) NWCI

NewCardio, Inc. is a company focused on cardiac diagnostics and related services. The firm specializes in developing innovative software technologies for non-invasive diagnosis and continuous monitoring of cardiovascular diseases.

Products and Services

• QTinno: Automated cardiac safety solution using advanced algorithms
• CardioBip: Mobile ECG system for remote data transmission
• my3KG: Software for comprehensive evaluation of cardiac electrical activity

Growth Outlook

• Increasing demand for non-invasive cardiac diagnostics in healthcare
• Expansion of product offerings to enhance market presence
• Focus on research and development to drive innovation

Financial Highlights

• Recent quarterly revenue of 9,883, indicating ongoing operational activity
• Trailing twelve months (TTM) gross profit margin of 40.83%, showcasing potential
• Current ratio of 0.72, reflecting short-term liquidity management

NewCardio, Inc. operates in the medical devices sector, specifically targeting the growing need for advanced cardiac monitoring solutions. The company's innovative products, such as QTinno and CardioBip, are designed to streamline traditional diagnostic methods, making them more efficient and accessible. With a focus on research and development, NewCardio aims to expand its product offerings and enhance its market presence. The growth outlook for NewCardio is promising, driven by the increasing demand for non-invasive cardiac diagnostics and the company's commitment to innovation. Recent financial data indicates operational activity, with a quarterly revenue of 9,883. The TTM gross profit margin of 40.83% suggests that the company has the potential for profitability as it continues to refine its offerings. Additionally, a current ratio of 0.72 indicates that NewCardio is managing its short-term liquidity effectively, which is crucial for sustaining operations and funding future growth initiatives. Overall, NewCardio, Inc. presents an intriguing opportunity for investors interested in the healthcare sector, particularly in the realm of cardiac diagnostics and monitoring technologies.